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Abstract
Dı́az, J, ÁlvarezHerms, J,Castañeda,A, Larruskain, J,Ramı́rezde laPiscina, X,Borisov,OV,Semenova,EA,Kostryukova, ES,Kulemin,NA,
Andryushchenko, ON, Larin, AK, Andryushchenko, LB, Generozov, EV, Ahmetov, II, and Odriozola, A. The GALNTL6 gene rs558129
polymorphism is associated with power performance. J Strength Cond Res 34(11): 3031–3036, 2020—The largest genome-wide asso-
ciation study to date in sports genomics showed that endurance athletes were 1.23 times more likely to possess the C allele of the single
nucleotide polymorphism rs558129ofN-acetylgalactosaminyltransferase-like 6gene (GALNTL6), comparedwith controls.Nevertheless, no
further study has investigated GALNTL6 gene in relation to physical performance. Considering that previous research has shown that the
same polymorphism can be associated with both endurance and power phenotypes (ACTN3, ACE, and PPARA), we investigated the
associationbetweenGALNTL6 rs558129polymorphismandpowerperformance.According to this objectiveweconducted2global studies
regarding 2 different communities of athletes in Spain andRussia. The first study involved 85Caucasian physically activemen from the north
of Spain to perform a Wingate anaerobic test (WAnT). In the second study we compared allelic frequencies between 173 Russian power
athletes (49 strength and 124 speed-strength athletes), 169 endurance athletes, and 201 controls.We found that physically activemenwith
the T allele ofGALNTL6 rs558129 had 5.03–6.97%higher power values comparedwith thosewith theCCgenotype (p, 0.05). Consistent
with these findings, we have shown that the T allele was over-represented in power athletes (37.0%) compared with endurance athletes
(29.3%;OR51.4,p50.032) andcontrols (28.6%;OR51.5,p50.015). Furthermore, thehighest frequencyof theTallelewasobserved in
strength athletes (43.9%; odds ratio [OR]5 1.9, p 5 0.0067 compared with endurance athletes; OR 5 2.0, p 5 0.0036 compared with
controls). In conclusion, our data suggest that the GALNTL6 rs558129 T allele can be favorable for anaerobic performance and strength
athletes. In addition, we propose a new possible functional role of GALNTL6 rs558129, gut microbiome regarding short-chain fatty acid
regulation and their anti-inflammatory and resynthesis functions. Nevertheless, further studies are required to understand the mechanisms
involved.
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Introduction
Athletic performance depends on multifactorial factors including the
specific physical requirements for any sport. Thus, each sport disci-
pline could be particularly described by a specific physiological
phenotype-based performance (endurance, strength, or power).
Strength power performance is the result of the interaction between
force and velocity during the movement (sprinting, jumping,
weightlifting). The use of genetic biomarkers associatedwith different
specific athletic performance could exhibit clear or null tendencies to
develop the physiology for the specific maximal performance (11).
In this regard, the study of genetic factors of complex phenotypes
could be very important to predict endurance performance. An im-
portant goal of exercise training lies in providing a perfect specific
stimulus to achieve the greater fitness for each individual (5). Genetic
predisposition to different physical performances as endurance is re-
quired to reach elite athletic status in activities as speed or endurance
(11). For instance, approximately 66%of the variance in athlete status
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could be attributed to genetic factors (7). The analysis of genetic var-
iants (i.e., DNA polymorphisms) comparing athletes and disciplines
could be very important to understand the innate predisposition to
better specific performance (11). Strength and power performance
phenotypes, besides environmental factors, are highly influenced by
genetic factors, but of a polygenic nature (5). From the elegant studies
of Montgomery et al. (24), different genetic variations as insertion/
deletion of polymorphism have been largely reported. More recently,
Bray et al. (6) reported more than 200 genetic variations potentially
associated with physical performance phenotypes. Given the impor-
tance to optimize training and provide specific stimulus in athletes, the
interest inknowinggenetic informationhasgrown importantly the last
decades to improve individualizationof thepreparation (22,36).Sports
genetics research has suffered a paradigm shift, and candidate gene
approaches, usually with a limited number of genetic variants and
small sample sizes, are being replaced by genome-wide association
studies (GWAS) (36). This movement into the genomics era implies
unbiased examinations of a genome-wide set of genetic variants in
large and collaborative projects followed by validations and replica-
tions studies across sex and ethnicity (36).
The main advance in genetics applied to performance has
come from the development of the number of GWAS to identify
single nucleotide polymorphisms (SNPs) of elite athlete status
and related phenotypes around, but the results obtained from
this new perspective is still limited and inconclusive (1,33,38).
However, recently Rankinen et al. (33) have published the
largest sample to date in an attempt to find common genetic
variants of elite endurance performance.
This study comes from the establishment of an international
consortium (GAMES) with 45 promising endurance markers
from 2 GWAS. Seven additional cohorts of Olympic and World
level athletes and sedentary controls from Australia, Ethiopia,
Japan, Kenya, Poland, Russia, and Spain were analyzed. Despite
the main conclusion that there is no genomic variant common to
athlete groups from different populations, when the results from
all cohorts were pooled together in a meta-analysis, only
rs558129 C/T located in the last intron of N-
acetylgalactosaminyltransferase-like 6 gene (GALNTL6) was
statistically significant (p 5 0.0002). In particular, endurance
athletes were 1.23 times more likely to possess the C allele com-
pared with controls. As has been previously published, greater
specific physical performance has an important genetic compo-
nent both for aerobic and anaerobic activities (4). From a physi-
ological perspective, anaerobic exercises require high-power
muscle contraction depending on specific metabolic pathways
that use creatine phosphate, adenosine triphosphate, and glu-
cose (37).
Although replication of the results of the GAMES consortium
projects is necessary to validate them, to the best knowledge of the
authors, no further study has investigated theGALNTL6 gene in
other populations of different ethnicity or gender. Considering
that previous researches have shown that the same polymorphism
can be associated with both endurance and power phenotypes
(ACTN3, ACE, AGTR2, HIF1A,and PPARA) (8,13,22,36), we
investigated the association between GALNTL6 rs558129
polymorphism, power (anaerobic) performance in physically
active men from the north of Spain (Basque Country), and power
athlete status in Russians. For that end, Wingate anaerobic test
(WAnT), a 30-second supramaximal cycling test has been used,
because of the fact that it is a noninvasive, fast, and reliable way to
measure maximal and mean power (30).
Methods
Experimental Approach to the Problem
To test the hypothesis that GALNTL6 gene rs558129 poly-
morphism is associated with anaerobic performance in a pop-
ulation of 85 Caucasian physically active men from the north of
Spain (Basque Country), we performed a genotype-phenotype
study using WAnT, and case-control study involving 543 sub-
jects, to show that genetic variation associated with improved
anaerobic performance is favorable for power athletes.
Subjects
Ethical approval. The study was approved by the Human Re-
search Ethics Committee of the School of Science and Technol-
ogy, University of the Basque Country (UPV/EHU)
(M10_2017_108) and the Ethics Committee of the Federal Re-
search and Clinical Center of Physical-chemical Medicine of the
Federal Medical and Biological Agency of Russia. All subjects
signed an informed consent form which included: (a) the goal of
the study; (b) a statement for the unique use of the samples for this
study; and (c) explicit anonymity about the final genetic result.
The study complied with the guidelines set out in the Declaration
of Helsinki and ethical standards in sport and exercise science
research. The experimental procedures were conducted following
the set of guiding principles for reporting the results of genetic
association studies defined by the STrengthening the REporting
of Genetic Association studies (STREGA) Statement.
Spanish cohort.We enrolled 85 physically activemen in this study
(39.26 7.9 years; bodymasss: 73.26 7.2 kg; height: 176.76 5.9
cm). The subjects general characteristics are shown in Table 1.
The requirements to participate in the study were (a) a 10–14
hours of physical activity per week mainly based on endurance
training and soft power training, during more than 2 years, (b) to
refrain from conducting any kind of power training, such as
powerlifting, sprints or short distance fast running, and (c) not to
have taken doping substances or doping penalties. Therefore,
Table 1
Characteristics of physically active men (n 5 85) across GALNTL6 rs558129 genotypes and using the dominant allele model.
Characteristics
Genotypes
pC/C [n 5 38] C/T [n 5 36] T/T [n 5 11] C/t 1 T/T [n 5 47]
Frequencies (%) 45.2 42.8 11.9 33.3
Age 40 6 8 39 6 8 39 6 10 38.7 6 8.2 0.662
Height (cm) 176.4 6 5.9 177.0 6 5.6 176.4 6 7.0 176.8 6 5.9 0.730
Body mass (kg) 73.8 6 7.3 73.6 6 7.3 71.8 6 4.3 73.2 6 6.8 0.698
Sum of skinfolds (mm) 82.2 6 28.7 73.6 6 23.0 68.5 6 26.2 72.5 6 23.5 0.098
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subjects have not been treated or hospitalized for the last 12
months.
Russian Cohort. The Russian study involved 173 elite power (48
strength and 125 speed-strength athletes) athletes, 169 endurance
athletes, and 201 controls (45 women, 156 men). Strength ath-
letes included 35 weightlifters and 13 powerlifters. The group of
speed-strength athletes was composed of 68 wrestlers, 5
decathletes/heptathletes, 25 rugby players, 20 jumpers (athletics),
and 7 throwers. Endurance athletes included 32 biathletes, 92
cross-country skiers, 2marathon runners, 14 5–25 km swimmers,
8 race walkers, and 21 triathletes. All athletes (n 5 342; 166
females, 176males) wereOlympic teammemberswho have tested
negative for doping substances.
Procedures
Genotyping: Spanish cohort. Saliva samples were obtained using
buccal swabs (4N6FLOQSwab; Life Technologies, Carlsbad,
CA). DNA was extracted via QIAmp DNA Mini Kit (Qiagen,
Hilden, Germany), and quantified by fluorometry using Qubit
(Life Technologies) and Quant-iT PicoGreen dsDNA Assay Kit
(Invitrogen, Carlsbad, CA). DNA samples were genotyped using
an single nucleotide polymorphism (SNP) type assay specifically
designed for rs558129, in the Biomark HD System (Fluidigm,
South San Francisco, CA).
Russian Cohort. Molecular genetic analysis in all Russian ath-
letes and controls was previously described (16). Briefly, geno-
typing of DNA samples (obtained from leukocytes) was
conducted using micro-array analysis. Initially, 4 ml of venous
bloodwere collected in tubes containing EDTA (Vacuette EDTA
tubes, Greiner Bio-One, Austria). Blood samples were trans-
ported to the laboratory at 4° C and DNA was extracted on the
same day. DNA extraction and purification were performed
using a commercial kit according to the manufacturer’s in-
structions (Technoclon, Russia) and included chemical lysis,
selective DNA binding on silica spin columns and ethanol
washing. Extracted DNA quality was assessed by agarose gel
electrophoresis at this step. HumanOmni1-Quad BeadChips
(Illumina, Inc., San Diego, CA) were used for genotyping of
1,140,419 SNPs in athletes and controls. The assay required 200
ng of DNA sample as input with a concentration of at least 50
ng/mL. Exact concentrations of DNA in each sample were
measured using a Qubit Fluorometer (Invitrogen). All further
procedures were performed according to the instructions of
Infinium HD Assay.
Anthropometric measurements. The following variables were
assessed for each Spanish subject: height, body mass (BM), and 6
skinfolds (SF) thickness. The SF thicknesses were measured using
HoltainCallipers. All anthropometric measurements were per-
formed in compliance with the International Society of Ad-
vancement of Kinanthropometry protocol (17) by the same
anthropometrists and the sum of folds was calculated (Table 1).
Anaerobic testing. The experimental protocol was double-
blinded in the sense that neither the evaluators nor the subjects
knew the genotype during the anaerobic test. All cycle testing
were performed on an air-braked validated cycle ergometer
(Wattbike Pro, Nottingham, United Kingdom). Wattbike er-
gometer was calibrated on a dynamic calibration rig using a first-
principles approach by specialists at the Australian Institute of
Sport (14). The 48 hours preceding the tests, they abstained from
any physical activity thatmay influence the results (15). Before the
WAnT, each subject was allowed a 10-minutewarm-up period on
the cycle ergometer at 65% of their maximum heart rate based on
their age, according to Karvonen protocol. Heart rate was mea-
sured by the S625X heart rate monitor (Polar Electro, Kempele,
Finland). After the warm-up, there was a 120-second period of
setup time where subjects were instructed to sit passively before
proceeding to the WAnT. This test was performed at maximal
(all-out) effort for 30 seconds to evaluate one bout of anaerobic
performance (14). The air braking resistance was set to level l0
and magnetic resistance set to level 1 (equating to 1045W at 130
rpm and approximately 90–100 W increases for every further 5
rpm increase in cadence). The WAnT was started after 5 seconds
countdown being still. Subjects were verbally encouraged
throughout each of the testing protocols. The absolute and the
relative (per body mass in kilograms) mean power and the peak
power (PP) over the entire 30 seconds were calculated for each
subject.
Statistical analyses
A x2 test was used to assess whether genotype frequencies were in
Hardy-Weinberg equilibrium (HWE). The association of WAnT
performance (Mean power, Relative mean power, PP, and Rela-
tive PP) with nongenetic factors (age, height, body mass, and the
sum of 6 SF) was investigated using linear regression. Besides, the
association of GALNTL6 rs558129 with each outcome variable
was analyzed under dominant (C/C vs. C/T1T/T), recessive (T/T
vs. C/T 1 C/C), overdominant (C/T vs. C/C 1 T/T), and log-
additive (T/T5 2, C/T5 1, C/C5 0) modes of inheritance using
linear regression in the WG association function from the
SNPassoc package in R, adjusting for the nongenetic variables
significantly associatedwith each outcome variable. The resulting
p values for each outcome were corrected for multiple compari-
sons using the false discovery rate method. Genotype distribution
and allele frequencies between athletes and controls were com-
pared using x2 tests. The significance level was set at p , 0.05.
Statistical analyses were performed usingR version 3.2.3 (R Core
Team 2015, R Foundation for Statistical Computing, Vienna,
Austria) for Spanish population and GraphPad InStat (GraphPad
Software, Inc.) software for the Russian population.
Results
Genotype-Phenotype Study
GALNTL6 rs558129 genotypes exhibited a HWE distribution.
Sample characterization was conducted according to different
genotypes and using the dominant allele model (C/C vs. T-allele
carriers) in Table 1. There were no significant differences in
height, BM, and sum of SF across GALNTL6 rs558129 geno-
types.Wingate anaerobic test results were adjusted by age, height,
body mass, and sum of 6 SF. Mean and PP values (absolute and
relative to BM) of the WAnT concerning the GALNTL6
rs558129 genotypes and T-allele dominant model are shown in
Table 2. T-allele carriers had 5–7% higher absolute and relative
mean power and PP values than those with C/C genotype (p
, 0.05).
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Case-Control Study
In athletes and controls, the GALNTL6 rs558129 met Hardy-
Weinberg expectations (p. 0.05). The frequency of the T allele
was significantly higher in power athletes (37.0%) compared
with endurance athletes (29.3%; odds ratio [OR] 5 1.4, p 5
0.032) and controls (28.6%; OR 5 1.5, p 5 0.015) (Table 3).
Furthermore, the highest frequency of the T allele was observed
in strength athletes (43.9%; OR 5 1.9, p 5 0.0067 compared
with endurance athletes; OR 5 2.0, p 5 0.0036 compared with
controls).
Discussion
GAMES consortium conducted the highest genome-wide asso-
ciation study to date in an attempt to find common genetic
variants of elite endurance performance (33). As a result of that
study, the C allele of the rs558129 located inGALNTL6was the
only locus overrepresented in each analyzed population in
Olympic and world-level endurance athletes compared with
sedentary controls (OR 5 1.23) (33). Therefore, we propose to
study whether GALNTL6 rs558129 is associated to power
performance measured by widely used WAnT (30), in a pop-
ulation of 85 Caucasian physically active males and to further
validate the obtained results in a case-control study in a pop-
ulation of 543 power athletes.
The main findings of this study were that T allele carriers had
significantly higher power values in a WAnT than those with the
CC genotype (5–7% higher absolute and relative mean power
and PP) and that T allele was significantly over-represented in
power athletes compared with both endurance athletes and con-
trols (p , 0.05), suggesting a possible dominant mode of
inheritance.
In the current study, we have not observed the differences in the
T allele frequency between Russian endurance athletes and con-
trols, as was found in the study of Rankinen et al. (33), meaning
that the rs558129 SNP of theGALNTL6 gene has not been under
selection pressures in the Russian population. Therefore, to find
the significance of this SNP for endurance performance other than
case-control design methodology should be used. However, this
was beyond the scope of our study.
Based on our results, we propose that T allele of rs558129
polymorphism could have a positive effect in anaerobic me-
tabolism and C allele in aerobic metabolism, following the trend
of other sport-related genes of being associated with both en-
durance and power phenotypes such as I/D of ACE, R577X of
ACTN3, rs11091046 of AGTR2,P582S of HIF1A, and
rs4253778 of PPARA (10,15,26,29–31).For instance, the RR
genotype of ACTN3 R577X has been related to power/strength
performance, whereas the XX genotype has been related to
endurance performance (23). Another example is the I/D poly-
morphism in the ACE gene, whose I allele is an endurance-
related marker and theD allele has been associated with power/
strength athlete status (27,28).In this regard, previous meta-
analyses have reported the Odds Ratio data relative to the as-
sociation between physical performance and genotypes (ACE II;
OR 5 1.23; 95% confidence interval [CI] 1.05–1.45) (ACTN3
RR genotype; OR 5 1.21; 95% CI 1.03–1.42) (28).Here, we
found that the frequency of the T allele ofGALNTL6 rs558129
was significantly higher in power athletes (37.0%) compared
with endurance athletes (29.3%; OR 5 1.4, p 5 0.032) and
controls (28.6%; OR 5 1.5, p 5 0.015) (Table 3).
Although ACTN3 and ACE genes are functionally modu-
lating respectively muscle fiber composition and vasoconstric-
tion, the function of the GALNTL6 gene is not completely
understood now. The only available information about
rs558129 polymorphism of GALNTL6 comes from a GWAS
(33) and the current paper, but its possible downstream tran-
scriptional and translational effects have not been studied yet.
At gene level, it is known that GALNTL6 encodes N-
acetylgalactosaminyltransferase-like 6. GALNT6 is a GALNT
gene family member, such as GALTN13, that have been also
associated with power, reinforcing the idea that GALNT can
exert a role in sports performance. Hence, in a genome-wide
association study, the G allele of rs10196189 polymorphism in
GALNT13was significantly over-represented in a group of elite
Jamaican, African-American, and Japanese sprint athletes,
compared with their respective controls (38).
Overall, the GALNT gene family contributes to mucin-type
o-glycan biosynthesis, but is not known how they could in-
fluence sports performance. GALNTL6 is expressed primarily
in the gastrointestinal tract, in the testes and also in the brain and
muscle (32), and accordingly to GTEx portaldbGaP accession
number phs000424.v8.p2, the studied SNP (which is in 100%
LD with rs495911) is functional, with the T allele being asso-
ciated with increased expression of theGALNTL6 gene both in
testis (p5 3.0e-8) and in intestines (p5 1.9e-9).Consequently, it
has been suggested that it is involved in spermatogenesis and cell
maturation and differentiation of the brain, but its relations
with performance remain unclear and require further study.
Table 3
Distribution of GALNTL6 rs558129 genotypes and allelic
frequencies in Russian athletes and controls.*
Groups n
Genotypes p
CC CT TT T allele, % PA vs. EA PA vs. C
Power athletes 173 66 86 21 37.0 0.032† 0.015†
Endurance athletes 169 84 71 14 29.3 — —
Controls 201 99 89 13 28.6 — —
*PA 5 power athletes; EA 5 endurance athletes; C 5 controls.
†p , 0.05, statistically significant differences of T allele frequency.
Table 2
The results of the cycle sprint test across allGALNTL6 rs558129genotypes andusing the dominant allelemodel in physically activemen.*
Traits
Genotypes
pC/C (n 5 38) C/T (n 5 36) T/T (n 5 11) C/t 1 T/T (n 5 47)
Mean power (W) 682.2 6 9.5 718.7 6 11.8 717.5 6 26.7 718.4 6 10.8 0.003
Mean power/Body mass (W·kg21) 9.3 6 0.1 9.85 6 0.1 10.28 6 0.5 9.94 6 0.1 0.008
Peak power (W) 989.8 6 20.7 1,046.3 6 22.7 1,044.4 6 48.7 1,045.9 6 20.5 0.018
Peak power/Body mass (W·kg21) 13.46 6 0.2 14.33 6 0.3 14.96 6 0.9 14.47 6 0.3 0.027
*Values are expressed as mean 6 SD. Cycle sprint test results were adjusted by age, height, body mass, and sum of skinfolds. The p-value reflects the dominant allele comparison (C/C vs. C/T 1 T/T).
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From the authors’ knowledge, there has not been any pre-
vious proposal regarding the possible role of GALNTL6
expressed in intestines in sports performance. As the rest of the
member of GALNT family, GALNT6 O-glycosylation activity
plays an important role in the host-microbiota interactions as
the commensal bacteria use glycans as nutrient sources and at-
tachment sites (2).Fluctuations in the abundance of glycans and
their chemical variations have a profound effect on shaping the
proliferation of the own human gut microbiota (21). Indeed,
human gut microbiota affects health and physiology, providing
benefits such as modulation of immune development (34), di-
gestion of dietary nutrients (12), and inhibition of pathogen
colonization (40). As an example, O-glycosylation mediated by
GALNT6 could facilitate the digestion by gut microbiota of
glycans to short-chain fatty acids (SCFA) production, such as
butyrate, acetate, and propionate (39). Short-chain fatty acid
has an important role in the regulation of the immune system,
anti-inflammation and metabolism, and have been associated
with enhanced fitness and overall health in the comparison be-
tween athletes and sedentary group (3). Regarding metabolism,
n-butyrate, acetate, and propionate are carried in the blood-
stream to a variety of different organs where they are used as
substrates for energy metabolism, particularly by the hepatocyte
cells, which use propionate for gluconeogenesis (35).In this
regard, Estaki et al. demonstrated that fit individuals with best
cardiorespiratory fitness showed an increased gut microbial
diversity enriched in butyrate-producing taxa, such as Clos-
tridiales, Roseburia, Lachnospiraceae, and Erysipelotrichaceae
(10). From a physical performance perspective, it is possible
that Lactobacillus spp. influenced exercise performance by
producing lactic acid, which, in turn, could be used by lactate-
utilizing bacteria to produce butyrate (9). Likewise, high buty-
rate levels in rats are related to the predisposition to exercise
activity and better health (20). On the other hand, recently, a
shotgun metagenomic analysis in a cohort of elite athletes, has
revealed that: (a) major pathway metabolizing lactate to pro-
pionate is at higher relative abundance post-exercise, (b) lactate
crosses the epithelial barrier into the lumen of the gut, (c) Veil-
lonella relative abundance is increased in marathon runners
postmarathon, (d) Veillonela atypica use lactate as their sole
carbon source producing propionate, and (e) intrarectal in-
stillation of V. atypica or propionate in mice is sufficient to
increased treadmill run time performance.
Therefore, theGALNTL6 and GALNT family gene expression
in the intestines and their function related to the SCFAs production
could be important in the anaerobic performance in some pheno-
types which have benefits on the energy utilization, by acidosis
homeostasis due to lactate recycling (25). However, this hypothesis
related to GALNTL6 expression and gut microbiome regulation
requires further study and its association with anaerobic perfor-
mance in athletes. Similarly, the possibility of synergistic, compet-
itive, or even inhibitory effects among different isoforms of
GALNTgene family such asGALNT13 previously associatedwith
anaerobic performance should be considered, and it should be a
topic of future research (29).
In conclusion, our data suggest that theGALNTL6 rs558129
T allele could be favorable for anaerobic performance and
strength athletes. Validation in other cohorts and further studies
are necessary to address the detailed role of the GALNTL6
rs558129 polymorphism within the complex phenotype of
power performance. In addition to the effects of the present
polymorphism, other factors related to power such as environ-
mental factors and the potential effect of other genetic variants
or important regulatory systems such as epigenetics should be
studied (18). Moreover, mechanistic studies are required to in-
vestigate how GALNTL6 rs558129 and other GALNT gene
family isoforms could affect both aerobic and anaerobic per-
formance, and explore its role in the intestines regarding SCFAs
regulation and their anti-inflammatory and resynthesis
functions.
Practical Applications
The ideal plan of training for each athlete would provide
specific and sensible stimulus accordingly with their pheno-
type. The complexity of the interindividual variability makes
talent selection or training stimulus assessment using only
genetic or phenotypical information difficult. This is evident
from studies that have demonstrated cases of elite athletes
with genotypes contrary to the majority of phenotypes for a
specific performance (19). In this context, preliminary data
highlight the potential for the GALNTL6 rs558129 poly-
morphism, to be used along with other gene variations and
standard phenotypic assessment in training prescription.
Thus, the T allele may confer valuable information to be
contrasted with physiological and exercise training stimulus
and prescribe specific aerobic or anaerobic exercise on a more
individual level, both for athletes and the general population.
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